In addition, we demonstrated the therapeutic effect of Pyr-apelin-13 in diabetic PAD, since its prolonged administration resulted in improved blood flow reperfusion, vascular density and motor function in diabetic mice following hindlimb ischemia. The gene discussed is APLN; the disease is peripheral arterial disease.